Obi Greenman
Amministratore Delegato presso CERUS CORPORATION
Patrimonio netto: 5 M $ in data 30/06/2024
Posizioni attive di Obi Greenman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CERUS CORPORATION | Direttore/Membro del Consiglio | 21/04/2011 | - |
| Amministratore Delegato | 21/04/2011 | - | |
| Presidente | 21/04/2011 | - | |
| Corporate Officer/Principal | 01/01/1999 | 01/08/2008 | |
| Vendite & Marketing | 01/08/2008 | 21/04/2011 |
Storia della carriera di Obi Greenman
Precedenti posizioni note di Obi Greenman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/06/2010 | 11/08/2023 |
| Independent Dir/Board Member | 01/06/2010 | 11/08/2023 | |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1995 | 01/01/1995 |
| CHINOOK THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 23/06/2011 | - |
| Independent Dir/Board Member | 01/06/2010 | - |
Formazione di Obi Greenman
| Stanford University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CERUS CORPORATION | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Obi Greenman
- Esperienza
